Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Effects of Cannabinoids on Pro- and Anti-Inflammatory Cytokines: A Systematic Review of In Vivo Studies
Frances Henshaw, Lauren S. Dewsbury, Chai K. Lim, et al.
Cannabis and Cannabinoid Research (2021) Vol. 6, Iss. 3, pp. 177-195
Open Access | Times Cited: 98

Showing 1-25 of 98 citing articles:

Current understanding of plant-derived exosome-like nanoparticles in regulating the inflammatory response and immune system microenvironment
Qiaoli Yi, Zhijie Xu, Abhimanyu Thakur, et al.
Pharmacological Research (2023) Vol. 190, pp. 106733-106733
Open Access | Times Cited: 84
Phytocannabinoids: Exploring Pharmacological Profiles and Their Impact on Therapeutical Use
Nicoleta Mirela Blebea, Andreea Pricopie, Robert-Alexandru Vlad, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4204-4204
Open Access | Times Cited: 16
Cannabidiol y epilepsia: avances en su investigación como opción terapéutica
Cecilia Zavala‐Tecuapetla, Ana Canseco-Alba, Joaquín Manjarrez-Marmolejo, et al.
eNeurobiología (2025) Vol. 16, Iss. 40
Open Access | Times Cited: 1
Cannabis Bioactive Compound-Based Formulations: New Perspectives for the Management of Orofacial Pain
Giuseppina Crescente, Giuseppe Minervini, Carmela Spagnuolo, et al.
Molecules (2022) Vol. 28, Iss. 1, pp. 106-106
Open Access | Times Cited: 48
Cannabinoids Alleviate the LPS-Induced Cytokine Storm via Attenuating NLRP3 Inflammasome Signaling and TYK2-Mediated STAT3 Signaling Pathways In Vitro
Santosh Suryavanshi, Mariia Zaiachuk, Nazar Pryimak, et al.
Cells (2022) Vol. 11, Iss. 9, pp. 1391-1391
Open Access | Times Cited: 46
Endocannabinoid System as a Promising Therapeutic Target in Inflammatory Bowel Disease – A Systematic Review
Szymon Hryhorowicz, Marta Kaczmarek-Ryś, Aleksandra Zielińska, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 52
Cannabinoids and Inflammations of the Gut-Lung-Skin Barrier
Cristian Scheau, Constantin Căruntu, Ioana Anca Bădărău, et al.
Journal of Personalized Medicine (2021) Vol. 11, Iss. 6, pp. 494-494
Open Access | Times Cited: 49
Scientific Validation of Cannabidiol for Management of Dog and Cat Diseases
Isabella Corsato Alvarenga, Kiran S. Panickar, Hannah Hess, et al.
Annual Review of Animal Biosciences (2023) Vol. 11, Iss. 1, pp. 227-246
Open Access | Times Cited: 20
Replacing alfalfa hay with industrial hemp ethanol extraction byproduct and Chinese wildrye hay: Effects on lactation performance, plasma metabolites, and bacterial communities in Holstein cows
Yiqiang Wang, Qingyuan Yu, Xiaolin Wang, et al.
Frontiers in Veterinary Science (2023) Vol. 10
Open Access | Times Cited: 19
Neuroinflammation and neuroprogression in depression: Effects of alternative drug treatments
Brandon Richardson, Andrew J. Macpherson, Francis Rodriguez Bambico
Brain Behavior & Immunity - Health (2022) Vol. 26, pp. 100554-100554
Open Access | Times Cited: 24
Cannabinoids as Immune System Modulators: Cannabidiol Potential Therapeutic Approaches and Limitations
Abdel-ilah Aziz, Long C. Nguyen, Loubna Oumeslakht, et al.
Cannabis and Cannabinoid Research (2022)
Closed Access | Times Cited: 23
Characterization of the biochemical and behavioral effects of cannabidiol: implications for migraine
Rosaria Greco, Francavilla Miriam, Chiara Demartini, et al.
The Journal of Headache and Pain (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 13
Cannabidiol acts as molecular switch in innate immune cells to promote the biosynthesis of inflammation-resolving lipid mediators
Lukas K. Peltner, Lars Gluthmann, Friedemann Börner, et al.
Cell chemical biology (2023) Vol. 30, Iss. 12, pp. 1508-1524.e7
Closed Access | Times Cited: 13
Anti-inflammatory effects of cannabidiol in early stages of neuroinflammation induced by high-fat diet in cerebral cortex of rats
Aleksandra Opęchowska, Kacper Karpiuk, Andrii Zahorodnii, et al.
Toxicology and Applied Pharmacology (2024) Vol. 484, pp. 116856-116856
Open Access | Times Cited: 4
Possible Role of Cannabis in the Management of Neuroinflammation in Patients with Post-COVID Condition
Noemí Cárdenas‐Rodríguez, Iván Ignacio‐Mejía, José Correa‐Basurto, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3805-3805
Open Access | Times Cited: 4
Characterisation of components of an extract of hemp and preliminary assessment of anti-inflammatory activity in an ex vivo model of bovine endometritis
Ifat Parveen, Nathan R. Allen, Ruth Wonfor, et al.
South African Journal of Botany (2025) Vol. 180, pp. 254-264
Open Access
Cannabidiol Protects Against Neurotoxic Reactive Astrocytes‐Induced Neuronal Death in Mouse Model of Epilepsy
H. Ye, Yuhui Wan, Xin Wang, et al.
Journal of Neurochemistry (2025) Vol. 169, Iss. 3
Closed Access
Cannabidiol reverses myeloperoxidase hyperactivity in the prefrontal cortex and striatum, and reduces protein carbonyls in the hippocampus in a ketamine-induced schizophrenia rat model
Sofia de Almeida Queiroz, Linério Ribeiro de Novais Júnior, ANITA PACHECO, et al.
Schizophrenia Research (2025) Vol. 278, pp. 82-95
Closed Access
Molecular insights into anti-inflammatory activities of selected Indian herbs
Swapna Upadhyay, Rajan Swami, Shweta Shrivastava, et al.
Journal of Ayurveda and Integrative Medicine (2025) Vol. 16, Iss. 2, pp. 101081-101081
Open Access
Cannabidiol-based natural health products for companion animals: Recent advances in the management of anxiety, pain, and inflammation
Cindy H. J. Yu, H.P. Vasantha Rupasinghe
Research in Veterinary Science (2021) Vol. 140, pp. 38-46
Closed Access | Times Cited: 27
The effect of medical cannabis in inflammatory bowel disease: analysis from the UK Medical Cannabis Registry
Nishaanth Dalavaye, Simon Erridge, Martha Nicholas, et al.
Expert Review of Gastroenterology & Hepatology (2022) Vol. 17, Iss. 1, pp. 85-98
Open Access | Times Cited: 20
Structural Investigation of Beta-Cyclodextrin Complexes with Cannabidiol and Delta-9-Tetrahydrocannabinol in 1:1 and 2:1 Host-Guest Stoichiometry: Molecular Docking and Density Functional Calculations
Nat Triamchaisri, Pisanu Toochinda, Luckhana Lawtrakul
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1525-1525
Open Access | Times Cited: 11
Autoimmunity, cancer and COVID-19 abnormally activate wound healing pathways: critical role of inflammation
Péter Gál, Jan Brábek, Michal Holub, et al.
Histochemistry and Cell Biology (2022) Vol. 158, Iss. 5, pp. 415-434
Open Access | Times Cited: 17
The long-term impact of elevated C-reactive protein levels during pregnancy on brain morphology in late childhood
Anna Suleri, Elisabet Blok, Melisa Durkut, et al.
Brain Behavior and Immunity (2022) Vol. 103, pp. 63-72
Open Access | Times Cited: 16
Cannabidiol interacts with the FXR/Nrf2 pathway and changes the CB1/CB2 receptors ratio in gentamicin-induced kidney injury in rats.
Vahideh Hokmabadi, Azadeh Khalili, Seyed Ali Hashemi, et al.
PubMed (2023) Vol. 26, Iss. 3, pp. 343-350
Closed Access | Times Cited: 9
Page 1 - Next Page

Scroll to top